Table 1.
HBoV Detection | Positive/Tested (%) | ||
---|---|---|---|
Single-Infection | 23/886 (20.9) | ||
Co-Infection | 87/886 (79.1) | ||
Co-infections | HBoV + norovirus | 26/110 (23.7) | |
HBoV + HAdV | 20/110 (18.2) | ||
HBoV + RVA | 12/110 (11) | ||
HBoV + astrovirus | 5/110 (4.5) | ||
HBoV + sapovirus | 4/110 (3.6) | ||
HBoV + norovirus + HAdV | 8/110 (7.3) | ||
HBoV + RVA + HAdV | 4/110 (3.6) | ||
HBoV + RVA + norovirus | 3/110 (2.7) | ||
HBoV + norovirus+ sapovirus | 1/110 (0.9) | ||
HBoV + RVA + norovirus+ HAdV | 3/110 (2.7) | ||
HBoV + norovirus+ HAdV + astrovirus | 1/110 (0.9) | ||
Age groups (months) | |||
0 to ≤6 | 19/212 (9) | ||
>6 to ≤12 | 37/331 (11.2) | ||
>12 to ≤24 | 54/343 (15.7) * | ||
Gender | |||
Male | 69/488 (14.1) | ||
Female | 41/391 (10.5) | ||
Genotypes | |||
HBoV-1 | 39/102 (38) | ||
HBoV-2 | 41/102 (40) | ||
HBoV-3 | 22/102 (22) | ||
Regions | 2016 | 2017 | |
Northeast | 27/154 (17.5) | 23/180 (12.7) | 50/334 (14.9) |
Southeast | 9/70 (12.8) | 4/31 (12.9) | 13/101 (12.8) |
South | 37/254 (14.5) | 10/197 (5.1) * | 47/451 (10.4) |
* p < 0.05, Chi-square and Fisher’s exact tests.